- $0.45m
- $0.45m
- $2.55m
Brief: Nanovibronix Announces Painguard And Uroguard Approved By Health Canada As Licensed Medical Devices
Brief: Nanovibronix Inc Signed A Provider Agreement With EZ Health Care
Brief: NanoVibronix Extends Reach Of UroShield And PainShield Through MTSG’s International Network
Brief: Nanovibronix Further Expands Va Distribution Network To Include Sdvosb Delta Medical, Llc
Brief: Nanovibronix Announces Agreement With Medina Healthcare Limited For Distribution Of Uroshield And Painshield In European Market Expansion
Brief: Nanovibronix Announces Encouraging Interim Results In Real World Patient Study Of Uroshield
Brief: Nanovibronix Reports Third Quarter 2021 Financial Results
Brief: Nanovibronix Inc - Supply Chain Constraints Are Currently Challenge For Business
Brief: Nanovibronix Announces Positive Results From Indepenent, Double-Blind Trial Of Painshield
Brief: Nanovibronix Launching New, Transdermal Gel Containing Nano-Cannabidiol For Treatment Of Joint Pain And Reducing Inflammation
U.S. STOCKS ON THE MOVE-Home Depot, Tencent Music, General Motors, Qualigen, Tesla, Target
NanoVibronix hits over 2-year high as Q2 revenue jumps, loss narrows
Brief: Nanovibronix Reports Second Quarter 2021 Financial Results Provides Business Update
U.S. STOCKS ON THE MOVE-Tesla, Enlivex Therapeutics, Sesen Bio, Tecent Music, NanoVibronix
NanoVibronix jumps on plans to launch OTC pain management device
Brief: Nanovibronix Announces Plan To Expand Product Portfolio With Introduction Of Painshield Relief For Over-The-Counter (Otc) Use
U.S. STOCKS ON THE MOVE-WW International, AppHarvest, CohBar
U.S. STOCKS ON THE MOVE-CohBar, HyreCar, Wix.com
Nanovibronix jumps on Australia regulator nod for therapeutic device